Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 233

1.

Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice.

Fullana MN, Ruiz-Bronchal E, Ferrés-Coy A, Juárez-Escoto E, Artigas F, Bortolozzi A.

Glia. 2019 Jan 11. doi: 10.1002/glia.23593. [Epub ahead of print]

PMID:
30635928
2.

CIBERSAM: Ten years of collaborative translational research in mental disorders.

Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, Micó JA, Palomo T, Pazos Á, Pérez V, Saiz-Ruiz J, Sanjuán J, Tabarés-Seisdedos R, Crespo-Facorro B, Casas M, Vilella E, Palao D, Olivares JM, Rodriguez-Jimenez R, Vieta E.

Rev Psiquiatr Salud Ment. 2018 Nov 8. pii: S1888-9891(18)30095-8. doi: 10.1016/j.rpsm.2018.10.001. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30416047
3.

Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons.

Cathala A, Devroye C, Drutel G, Revest JM, Artigas F, Spampinato U.

Exp Neurol. 2019 Jan;311:57-66. doi: 10.1016/j.expneurol.2018.09.015. Epub 2018 Sep 23.

PMID:
30257183
4.

Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression.

Fullana MN, Ferrés-Coy A, Ortega JE, Ruiz-Bronchal E, Paz V, Meana JJ, Artigas F, Bortolozzi A.

Mol Neurobiol. 2018 Aug 7. doi: 10.1007/s12035-018-1288-1. [Epub ahead of print]

PMID:
30088175
5.

Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex.

Gasull-Camós J, Martínez-Torres S, Tarrés-Gatius M, Ozaita A, Artigas F, Castañé A.

Neuropharmacology. 2018 Sep 1;139:41-51. doi: 10.1016/j.neuropharm.2018.06.029. Epub 2018 Jun 22.

PMID:
29940206
6.

Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks.

Amat-Foraster M, Jensen AA, Plath N, Herrik KF, Celada P, Artigas F.

Neuropharmacology. 2018 Jul 15;137:13-23. doi: 10.1016/j.neuropharm.2018.04.022. Epub 2018 Apr 24.

PMID:
29702122
7.

Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies.

Artigas F, Celada P, Bortolozzi A.

Eur Neuropsychopharmacol. 2018 Apr;28(4):457-482. doi: 10.1016/j.euroneuro.2018.01.005. Epub 2018 Mar 8. Review.

PMID:
29525411
8.

[Qualitative analysis among electronic cigarette users: practices, use, representations].

Fontaine A, Artigas F.

Sante Publique. 2017 Nov-Dec;29(6):793-801. doi: 10.3917/spub.176.0793. French.

PMID:
29473393
9.

Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.

Alarcón-Arís D, Recasens A, Galofré M, Carballo-Carbajal I, Zacchi N, Ruiz-Bronchal E, Pavia-Collado R, Chica R, Ferrés-Coy A, Santos M, Revilla R, Montefeltro A, Fariñas I, Artigas F, Vila M, Bortolozzi A.

Mol Ther. 2018 Feb 7;26(2):550-567. doi: 10.1016/j.ymthe.2017.11.015. Epub 2017 Nov 29.

PMID:
29273501
10.

The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors.

Riga MS, Lladó-Pelfort L, Artigas F, Celada P.

Neuropharmacology. 2018 Nov;142:219-230. doi: 10.1016/j.neuropharm.2017.11.049. Epub 2017 Dec 6.

PMID:
29221792
11.

Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

Artigas F, Bortolozzi A, Celada P.

Eur Neuropsychopharmacol. 2018 Apr;28(4):445-456. doi: 10.1016/j.euroneuro.2017.10.032. Epub 2017 Nov 22. Review.

PMID:
29174531
12.

The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.

van den Munkhof HE, Arnt J, Celada P, Artigas F.

Eur Neuropsychopharmacol. 2017 Dec;27(12):1248-1257. doi: 10.1016/j.euroneuro.2017.10.034. Epub 2017 Nov 8.

PMID:
29128144
13.

Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex.

Santana N, Artigas F.

Front Neuroanat. 2017 Sep 28;11:87. doi: 10.3389/fnana.2017.00087. eCollection 2017. Review.

14.

Differential Patterns of Subcortical Activity Evoked by Glial GLT-1 Blockade in Prelimbic and Infralimbic Cortex: Relationship to Antidepressant-Like Effects in Rats.

Gasull-Camós J, Soto-Montenegro ML, Casquero-Veiga M, Desco M, Artigas F, Castañé A.

Int J Neuropsychopharmacol. 2017 Dec 1;20(12):988-993. doi: 10.1093/ijnp/pyx067.

15.

Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors.

Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U.

Neuropharmacology. 2017 Jun;119:91-99. doi: 10.1016/j.neuropharm.2017.04.001. Epub 2017 Apr 5.

PMID:
28390892
16.

Effects of Hallucinogens on Neuronal Activity.

Lladó-Pelfort L, Celada P, Riga MS, Troyano-Rodríguez E, Santana N, Artigas F.

Curr Top Behav Neurosci. 2018;36:75-105. doi: 10.1007/7854_2017_473. Review.

17.

Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats.

Gasull-Camós J, Tarrés-Gatius M, Artigas F, Castañé A.

Transl Psychiatry. 2017 Feb 21;7(2):e1038. doi: 10.1038/tp.2017.7.

18.

Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder.

Artigas F, Bortolozzi A.

Neuropsychopharmacology. 2017 Jan;42(1):371. doi: 10.1038/npp.2016.182. No abstract available.

19.

Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS.

Artigas F, Schenker E, Celada P, Spedding M, Lladó-Pelfort L, Jurado N, Núñez M, Santana N, Troyano-Rodriguez E, Riga MS, van den Munkhof H, Castañé A, Shaban H, Jay TM, Tripathi A, Godsil BP, Sebban C, Mariani J, Faure P, Takkilah S, Hughes ZA, Siok CJ, Hajos M, Wicke K, Gass N, Weber-Fahr W, Sartorius A, Becker R, Didriksen M, Bastlund JF, Tricklebank M, Risterucci C, Meyer-Lindenberg A, Schwarz AJ.

Nat Rev Drug Discov. 2017 Jan;16(1):1-2. doi: 10.1038/nrd.2016.205. Epub 2016 Nov 4.

PMID:
27811930
20.

Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex.

Riga MS, Teruel-Martí V, Sánchez C, Celada P, Artigas F.

Neuropharmacology. 2017 Feb;113(Pt A):148-155. doi: 10.1016/j.neuropharm.2016.09.024. Epub 2016 Sep 23.

PMID:
27671324

Supplemental Content

Loading ...
Support Center